Search for a doctor

C. Burcin Taner, M.D.

  1. General Surgeon
  2. Chair, Transplantation, Florida
Request an Appointment

Publications

  1. Jarmi T, Luo Y, Attieh RM, Qie Y, Gadd ME, Hundal T, Mao S, Murthy HS, Taner BC, Kharfan-Dabaja MA, Qin H. CAR T-cell therapy-paving the way for sensitized kidney transplant patients. Kidney Int. 2024 May; 105 (5):1124-1129 Epub 2024 Apr 02
    View PubMed
  2. Taner CB, Croome KP. What is the true cost of DCD liver transplant from a value-based perspective? Liver Transpl. 2024 Apr 22 [Epub ahead of print]
    View PubMed
  3. Brubaker AL, Sellers MT, Abt PL, Croome KP, Merani S, Wall A, Abreu P, Alebrahim M, Baskin R, Bohorquez H, Cannon RM, Cederquist K, Edwards J, Huerter BG, Hobeika MJ, Kautzman L, Langnas AN, Lee DD, Manzi J, Nassar A, Neidlinger N, Nydam TL, Schnickel GT, Siddiqui F, Suah A, Taj R, Taner CB, Testa G, Vianna R, Vyas F, Montenovo MI. US Liver Transplant Outcomes After Normothermic Regional Perfusion vs Standard Super Rapid Recovery. JAMA Surg. 2024 Apr 3 Epub 2024 Apr 03
    View PubMed
  4. Wang Y, Huang Y, Antwi SO, Taner CB, Yang L. Racial Disparities in Liver Disease Mortality Trends Among Black and White Populations in the United States, 1999-2020: An Analysis of CDC WONDER Database. Am J Gastroenterol. 2024 Apr 1; 119 (4):682-689 Epub 2023 Oct 13
    View PubMed
  5. Attieh RM, Wadei HM, Mao MA, Mao SA, Pungpapong S, Taner CB, Jarmi T, Cheungpasitporn W, Leeaphorn N. The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch. Am J Transplant. 2024 Mar 4 Epub 2024 Mar 04
    View PubMed
  6. Das I, Mathur AK, Aqel B, Harnois D, Mao S, Taner CB, Croome KP. " To sleep-perchance to dream ": Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion. Liver Transpl. 2024 Feb 9 Epub 2024 Feb 09
    View PubMed
  7. Wang Y, Huang Y, Sun C, Chung H, Taner CB, Yang L. Higher-Than-Expected Burden of Alcohol-Related Liver Diseases During COVID-19 Pandemic in the USA, with a Tapering Trend. J Gen Intern Med. 2024 Jan 16 [Epub ahead of print]
    View PubMed
  8. Croome KP, Perry DK, Taner CB. Reply: Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States. Liver Transpl 2024 Jan 1; 30 (1):E6-E7 Epub 2023 May 22
    View PubMed
  9. Croome KP, Brown TE, Mabrey RL, Sonnenwald SL, Burns JM, Mao SA, Clendenon JN, Nguyen JH, Perry DK, Maddox RG, Taner CB. Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States. Liver Transpl. 2023 Dec 1; 29 (12):1282-1291 Epub 2023 Apr 13
    View PubMed
  10. Wadiwala IJ, Garg P, Pham V, Taner CB, Farres H, Krishna M, Pham SM. Iatrogenic Acute Ascending Aortic Dissection During Combined Heart/Liver Transplant for Amyloidosis. Transplant Proc. 2023 Oct; 55 (8):1978-1980 Epub 2023 Aug 30
    View PubMed
  11. Rahman MA, Yilmaz I, Albadri ST, Salem FE, Dangott BJ, Taner CB, Nassar A, Akkus Z. Artificial Intelligence Advances in Transplant Pathology. Bioengineering (Basel). 2023 Sep 04; 10(9).
    View PubMed
  12. Tran BV, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, Florman SS, Tabrizian P, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Hoteit M, Levine MH, Cillo U, Vitale A, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Lerut J, Ciccarelli O, Nguyen MH, Melcher ML, Viveiros A, Schaefer B, Hoppe-Lotichius M, Mittler J, Nydam TL, Markmann JF, Rossi M, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Barbas AS, Agopian VG. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium. Liver Transpl. 2023 Jul 1; 29 (7):683-697 Epub 2023 Apr 10
    View PubMed
  13. De Carlis R, Paolo Muiesan Muiesan, Taner B. Donation after circulatory death: Novel strategies to improve the liver transplant outcome. J Hepatol. 2023 Jun; 78 (6):1169-1180
    View PubMed
  14. Eden J, Sousa Da Silva R, Cortes-Cerisuelo M, Croome K, De Carlis R, Hessheimer AJ, Muller X, de Goeij F, Banz V, Magini G, Compagnon P, Elmer A, Lauterio A, Panconesi R, Widmer J, Dondossola D, Muiesan P, Monbaliu D, de Rosner van Rosmalen M, Detry O, Fondevila C, Jochmans I, Pirenne J, Immer F, Oniscu GC, de Jonge J, Lesurtel M, De Carlis LG, Taner CB, Heaton N, Schlegel A, Dutkowski P. Utilization of livers donated after circulatory death for transplantation - An international comparison. J Hepatol. 2023 May; 78 (5):1007-1016 Epub 2023 Feb 04
    View PubMed
  15. Niazi SK, Brennan E, Spaulding A, Crook J, Borkar S, Keaveny A, Vasquez A, Gentry MT, Schneekloth T, Taner CB. Impact of Recipient Age at Liver Transplant on Long-term Outcomes. Transplantation. 2023 Mar 1; 107 (3):654-663 Epub 2022 Nov 10
    View PubMed
  16. Verna EC, Phipps MM, Halazun KJ, Markovic D, Florman SS, Haydel BM, Ruiz R, Klintmalm G, Lee DD, Taner B, Hoteit MA, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo FN, Melcher ML, Nguyen MH, Nydam TL, Markmann JF, Mobley C, Ghobrial RM, Langnas AN, Carney C, Berumen J, Schnickel GT, Sudan D, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Agopian V, US Multicenter HCC Transplant Consortium. Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. Liver Transpl. 2023 Jan 1; 29 (1):34-47 Epub 2022 Dec 23
    View PubMed
  17. Breuer E, Mueller M, Doyle MB, Yang L, Darwish Murad S, Anwar IJ, Merani S, Limkemann A, Jeddou H, Kim SC, Lopez-Lopez V, Nassar A, Hoogwater FJH, Vibert E, De Oliveira ML, Cherqui D, Porte RJ, Magliocca JF, Fischer L, Fondevila C, Zieniewicz K, Ramirez P, Foley DP, Boudjema K, Schenk AD, Langnas AN, Knechtle S, Polak WG, Taner CB, Chapman WC, Rosen CB, Gores GJ, Dutkowski P, Heimbach JK, Clavien PA. Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study. Ann Surg. 2022 Nov 1; 276 (5):846-853 Epub 2022 July 27
    View PubMed
  18. Mercado LA, Bhangu HK, Calderon E, Mathur AK, Aqel B, Musto KR, Watt KD, Rosen CB, Bolan C, LeGout JD, Taner CB, Harnois DM, Croome KP. DCD Liver Grafts Can Safely Be Used for Recipients With Grade I-II Portal Vein Thrombosis: A Multicenter Analysis. Transplant Direct. 2022 Nov; 8 (11):e1392 Epub 2022 Oct 07
    View PubMed
  19. Croome KP, Mathur AK, Aqel B, Yang L, Taner T, Heimbach JK, Rosen CB, Paz-Fumagalli R, Taner CB. Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort. Transplantation. 2022 Jun 1; 106 (6):1206-1214 Epub 2022 Aug 30
    View PubMed
  20. Croome KP, Mao S, Taner CB. The Current Landscape of Liver Transplantation After Ex Situ Machine Perfusion and Normothermic Regional Perfusion in the United States. Liver Transpl. 2022 Jun; 28 (6):1108-1112 Epub 2022 Feb 11
    View PubMed
  21. Schlegel A, van Reeven M, Croome K, Parente A, Dolcet A, Widmer J, Meurisse N, De Carlis R, Hessheimer A, Jochmans I, Mueller M, van Leeuwen OB, Nair A, Tomiyama K, Sherif A, Elsharif M, Kron P, van der Helm D, Borja-Cacho D, Bohorquez H, Germanova D, Dondossola D, Olivieri T, Camagni S, Gorgen A, Patrono D, Cescon M, Croome S, Panconesi R, Carvalho MF, Ravaioli M, Caicedo JC, Loss G, Lucidi V, Sapisochin G, Romagnoli R, Jassem W, Colledan M, De Carlis L, Rossi G, Di Benedetto F, Miller CM, van Hoek B, Attia M, Lodge P, Hernandez-Alejandro R, Detry O, Quintini C, Oniscu GC, Fondevila C, Malago M, Pirenne J, IJzermans JNM, Porte RJ, Dutkowski P, Taner CB, Heaton N, Clavien PA, Polak WG, Muiesan P, DCD Collaborator Group. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation. J Hepatol. 2022 Feb; 76 (2):371-382 Epub 2021 Oct 14
    View PubMed
  22. Niazi SK, Vargas E, Spaulding A, Crook J, Keaveny AP, Schneekloth T, Rummans T, Taner CB. Impact of County Health Rankings on Nationwide Liver Transplant Outcomes. Transplantation. 2021 Nov 1; 105 (11):2411-2419
    View PubMed
  23. Sussman J, Calderon E, Ubl DS, Croome KP, Taner CB, Heimbach JK, Moss A, Habermann EB, Mathur AK. Variation in opioid prescribing patterns after abdominal transplant surgery. Clin Transplant. 2021 Oct; 35 (10):e14439 Epub 2021 Aug 09
    View PubMed
  24. Schlegel A, Foley DP, Savier E, Flores Carvalho M, De Carlis L, Heaton N, Taner CB. Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation. Transplantation. 2021 Sep 1; 105 (9):1892-1903
    View PubMed
  25. Wadei HM, Keaveny AP, Taner CB, Yang L, Mai ML, Hodge DO, White LJ, Mao SA, Jarmi T, Croome KP. Post-Liver Transplant Early Allograft Dysfunction Modifies the Effect of Pre-Liver Transplant Renal Dysfunction on Post-Liver Transplant Survival. Liver Transpl. 2021 Sep; 27 (9):1291-1301 Epub 2021 July 21
    View PubMed
  26. Wadei HM, Burcin Taner C, Keaveny AP, Mai ML, Hodge DO, White LJ, Harnois DM, Mao SA, Jarmi T, Croome KP. The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center. Ann Hepatol. 2021 Sep-Oct; 24:100317 Epub 2021 Feb 03
    View PubMed
  27. Wijarnpreecha K, Li F, Xiang Y, Xu X, Zhu C, Maroufy V, Wang Q, Tao W, Dang Y, Pham HA, Zhou Y, Li J, Zhang X, Xu H, Taner CB, Yang L, Tao C. Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Aliment Pharmacol Ther. 2021 Aug; 54(4):481-492. Epub 2021 Jul 05.
    View PubMed
  28. Sorrells WS, Mao SA, Taner T, Jadlowiec CC, Farres H, Davila V, Money SR, Stone WM, Al-Khasawneh M, Da Rocha-Franco JADR, Oldenburg WA, Oderich GS, Taner CB, Hakaim AG, Erben Y. Endarterectomy for Iliac Occlusive Disease during Kidney Transplantation: A Multicenter Experience. Int J Angiol. 2021 Jun; 30 (2):91-97 Epub 2020 Aug 30
    View PubMed
  29. Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, Kwo P, Nguyen M, Melcher ML, Busuttil RW, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Burcin Taner C, Hoteit MA, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Nydam TL, Markmann JF, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Agopian V, Dhanasekaran R. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl. 2021 May; 27 (5):684-698 Epub 2021 Mar 01
    View PubMed
  30. De la Garza-Ramos C, Muneer MS, Lewis JT, Harnois DM, Taner CB, Frey GT, Rosser B, Toskich BB. Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting. Radiol Case Rep. 2021 Apr; 16 (4):975-978 Epub 2021 Feb 15
    View PubMed
  31. Aqel B, Wijarnpreecha K, Pungpapong S, Taner CB, Reddy K, Leise M, Mi L, Dickson RC. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients. J Hepatol. 2021 Apr; 74 (4):873-880 Epub 2020 Nov 12
    View PubMed
  32. Croome KP, Taner CB. Expanding Role of Donation After Circulatory Death Donors in Liver Transplantation. Clin Liver Dis. 2021 Feb; 25 (1):73-88 Epub 2020 Oct 20
    View PubMed
  33. Croome KP, Livingston D, Croome S, Keaveny AP, Taner CB, Nakhleh R. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat? Liver Transpl. 2021 Feb; 27 (2):248-256
    View PubMed
  34. Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 Dec; 72 (6):2014-2028
    View PubMed
  35. Wijarnpreecha K, Pungpapong S, Aby ES, Croome KP, Taner CB, Thompson CC, Kroner PT. Simultaneous liver transplant and sleeve gastrectomy not associated with worse index admission outcomes compared to liver transplant alone - a retrospective cohort study. Transpl Int. 2020 Nov; 33 (11):1447-1452 Epub 2020 Sept 03
    View PubMed
  36. Croome KP, Mathur AK, Mao S, Aqel B, Piatt J, Senada P, Heimbach JK, Moss A, Rosen CB, Taner CB. Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis. Am J Transplant. 2020 Sep; 20 (9):2449-2456 Epub 2020 Apr 15
    View PubMed
  37. Cockerill KJ, Kahn AE, Young SM, Ball CT, Mai ML, Taner CB, Perry DK, Thiel DD. Mayo Adhesive Probability (MAP) score of non-donated kidney aids in predicting post-operative renal function following donor nephrectomy. BMC Urol. 2020 Aug 17; 20 (1):124
    View PubMed
  38. DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg. 2020 Apr; 271 (4):616-624
    View PubMed
  39. Niazi SK, Vargas E, Spaulding A, Sareyyupoglu B, Shah SZ, Schneekloth T, Crook J, Vasquez AR, Taner C. Nationwide Study of County Health Rankings and Lung Transplant Outcomes. J Heart Lung Transplant. 2020 Apr; 39 (4S):S365 Epub 2020 Mar 30
    View PubMed
  40. Niazi SK, Spaulding A, Vargas E, Schneekloth T, Crook J, Rummans T, Taner CB. Mental health and chemical dependency services at US transplant centers. Am J Transplant. 2020 Apr; 20 (4):1152-1161 Epub 2019 Dec 01
    View PubMed
  41. Pham AN, Patel PC, Landolfo K, Burns JM, Yip DS, Leoni Moreno JC, Goswami RM, Jacob S, El-Sayed Ahmed MM, Makey IA, Thomas M, Mai ML, Taner CB, Pham SM. Kidney transplantation on extracorporeal life support for primary cardiac allograft dysfunction. J Card Surg. 2020 Mar; 35 (3):725-728 Epub 2020 Feb 04
    View PubMed
  42. Croome KP, Mao S, Yang L, Pungpapong S, Wadei HM, Taner CB. Improved National Results With Simultaneous Liver-Kidney Transplantation Using Donation After Circulatory Death Donors. Liver Transpl. 2020 Mar; 26 (3):397-407 Epub 2020 Feb 03
    View PubMed
  43. Croome KP, Taner CB. The Changing Landscapes in DCD Liver Transplantation. Curr Transplant Rep. 2020; 7 (3):194-204 Epub 2020 July 13
    View PubMed
  44. Wadei HM, Abader P, Alsaad AA, Croome K, Cortese C, Geiger XJ, Khouzam S, Mai ML, Taner CB, Keaveny AP. Arterial Blood Pressure at Liver Transplant Evaluation Predicts Renal Histology in Candidates With Renal Dysfunction. Liver Transpl. 2019 Dec; 25 (12):1756-1767 Epub 2019 Oct 31
    View PubMed
  45. Chadha RM, Croome KP, Aniskevich S, Pai SL, Nguyen J, Burns J, Perry D, Taner CB. Intraoperative Events in Liver Transplantation Using Donation After Circulatory Death Donors. Liver Transpl. 2019 Dec; 25 (12):1833-1840 Epub 2019 Oct 18
    View PubMed
  46. Livingston D, Lee DD, Croome S, Burcin Taner C, Croome KP. Comparison of Supraceliac and Infrarenal Aortic Conduits in Liver Transplantation: Is There a Difference in Patency and Postoperative Renal Dysfunction? Transplant Direct. 2019 Nov; 5 (11):e499 Epub 2019 Oct 08
    View PubMed
  47. Croome KP, Lee DD, Croome S, Nakhleh RE, Abader Sedki Senada P, Livingston D, Yataco M, Taner CB. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort. Liver Transpl. 2019 Oct; 25 (10):1533-1540 Epub 2019 July 08
    View PubMed
  48. Croome KP, Lee DD, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner CB. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant. 2019 Sep; 19 (9):2550-2559 Epub 2019 Mar 26
    View PubMed
  49. Ferman TJ, Keaveny AP, Schneekloth T, Heckman MG, Vargas E, Vasquez A, Rummans T, Taner CB, Niazi SK. Liver Transplant Recipients Older Than 60 Years Show Executive and Memory Function Improvement Comparable to Younger Recipients. Psychosomatics. 2019 Sep - Oct; 60 (5):488-498 Epub 2019 Jan 23
    View PubMed
  50. Loh CA, Croome KP, Burcin Taner C, Keaveny AP. Bias-corrected estimates of reduction of post-surgery length of stay and corresponding cost savings through the widespread national implementation of fast-tracking after liver transplantation: a quasi-experimental study. J Med Econ. 2019 Jul; 22 (7):684-690 Epub 2019 Apr 02
    View PubMed
  51. Croome KP, Mathur AK, Pungpapong S, Lee DD, Moss AA, Rosen CB, Heimbach JK, Taner CB. Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral Era. Transplantation. 2019 Jun; 103 (6):1168-1174
    View PubMed
  52. Croome KP, Lee DD, Taner CB. The "Skinny" on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review. Liver Transpl. 2019 Mar; 25 (3):488-499
    View PubMed
  53. Cockerill KJ, Young S, T Ball C, Custer K, Taner CB, Perry DK, Thiel DD. The Association of the Mayo Adhesive Probability (MAP) Score With Total Operative Time in Patients Undergoing Hand-assisted Laparoscopic Donor Nephrectomy. Urology. 2019 Feb; 124:142-147 Epub 2018 Nov 08
    View PubMed
  54. Palmer WC, Taner CB, Keaveny AP, Nakhleh RE, Nguyen JH, Rosser BG Jr. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplant Proc. 2018 Dec; 50 (10):3606-3614 Epub 2018 Sept 08
    View PubMed
  55. Lee DD, Paz-Fumagalli R, Croome KP, Paz D, Wright L, Nguyen JH, Taner CB. Hepatic artery stenosis after liver transplant: Donation after cardiac death donor vs donation after brain death donor grafts. Clin Transplant. 2018 Nov; 32 (11):e13413 Epub 2018 Oct 28
    View PubMed
  56. Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Nidamanuri S, Rodriguez E, Franco D, Ryland K, Keaveny AP, Huskey JL, Smith M, Reddy KS, Taner CB, Vargas HE, Aqel BA. Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant. 2018 Oct; 18 (10):2559-2565 Epub 2018 June 08
    View PubMed
  57. Lee DD, Paz-Fumagalli R, Croome KP, Paz D, Wright L, Nguyen JH, Taner CB. Hepatic artery stenosis after liver transplant: DCD vs DBD grafts. Clinical Transplantation. 2018.
  58. Niazi SK, Schneekloth TD, Vasquez AR, Keaveny AP, Davis S, Picco M, Heckman MG, Diehl NN, Jowsey-Gregoire SG, Rummans TA, Burcin Taner C. Impact of psychiatric comorbidities on outcomes of elderly liver transplant recipients. J Psychosom Res. 2018 Aug; 111:27-35 Epub 2018 May 17
    View PubMed
  59. Croome KP, Mathur AK, Lee DD, Moss AA, Rosen CB, Heimbach JK, Taner CB. Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis. Transplantation. 2018 Jul; 102 (7):1108-1114
    View PubMed
  60. Lee DD, Croome KP, Musto KR, Melendez J, Tranesh G, Nakhleh R, Taner CB, Nguyen JH, Patel T, Harnois DM. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl. 2018 May; 24 (5):634-644
    View PubMed
  61. Wadei HM, Lee DD, Croome KP, Mai L, Leonard D, Mai ML, Taner CB, Keaveny AP. Early Allograft Dysfunction Is Associated With Higher Risk of Renal Nonrecovery After Liver Transplantation. Transplant Direct. 2018 Apr; 4 (4):e352 Epub 2018 Mar 14
    View PubMed
  62. Croome KP, Lee DD, Burns JM, Keaveny AP, Taner CB. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard. Liver Transpl. 2018 Apr; 24 (4):488-496
    View PubMed
  63. Croome KP, Lee DD, Pungpapong S, Keaveny AP, Taner CB. What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list? Liver Transpl. 2018 Apr; 24 (4):497-504
    View PubMed
  64. Croome KP, Mathur AK, Lee DD, Moss AA, Rosen CB, Heimbach JK, Taner CB. Outcomes of Donation After Cardiac Death Liver Grafts from Donors >/= 50 years of Age: A Multi-center Analysis. Transplantation. 2018 Jan 31 [Epub ahead of print]
    View PubMed
  65. Niazi S, Schneekloth T, Taner CB. Elderly recipients of liver transplantation: impact of age and psychosocial variables on outcome. Curr Opin Organ Transplant. 2017 Dec; 22 (6):588-592
    View PubMed
  66. Trautman CL, Palmer WC, Taner CB, Canabal JM, Getz T, Goldman A, Heckman MG, Diehl NN, Lee DD, Stancampiano FF. Thromboelastography as a Predictor of Outcomes Following Liver Transplantation. Transplant Proc. 2017 Nov; 49 (9):2110-2116
    View PubMed
  67. Aniskevich S, Chadha RM, Peiris P, Taner CB, Torp KL, Thomas CS, Yataco ML, Pai SL. Intra-operative predictors of postoperative Takotsubo syndrome in liver transplant recipients-An exploratory case-control study. Clin Transplant. 2017 Nov; 31 (11) Epub 2017 Sept 14
    View PubMed
  68. Taner B, Mendez-Sanchez N. In memoriam. Thomas Starzl, M.D., Ph.D. Ann Hepatol. 2017 Oct 16; 16 (6):981-982
    View PubMed
  69. Lee DD, Li J, Wang G, Croome KP, Burns JM, Perry DK, Nguyen JH, Hopp WJ, Taner CB. Looking inward: The impact of operative time on graft survival after liver transplantation. Surgery. 2017 Oct; 162 (4):937-949 Epub 2017 July 03
    View PubMed
  70. Taner CB, Keaveny AP. Innovative care models after liver transplant. Clin Liver Dis (Hoboken). 2017 Sep; 10 (3):68-71 Epub 2017 Sept 29
    View PubMed
  71. Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg. 2017 Sep; 266 (3):525-535
    View PubMed
  72. Croome KP, Lee DD, Nguyen JH, Keaveny AP, Taner CB. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores. Am J Transplant. 2017 Sep; 17 (9):2420-2427 Epub 2017 July 07
    View PubMed
  73. Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible Donors as a Strategy to Decrease the Organ Shortage. Am J Transplant. 2017 Jun; 17 (6):1649-1655 Epub 2017 Jan 31
    View PubMed
  74. Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL. Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium. Transplantation. 2017 May; 101 (5):1067-1073
    View PubMed
  75. Croome KP, Lee DD, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017 Mar; 23 (3):342-351
    View PubMed
  76. Croome KP, Lee DD, Harnois D, Taner CB. Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma. PLoS One. 2017; 12 (1):e0170673 Epub 2017 Jan 25
    View PubMed
  77. Croome KP, Lee DD, Keaveny AP, Taner CB. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors. Transplantation. 2016 Dec; 100 (12):2640-2647
    View PubMed
  78. Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB. Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection. Ann Hepatol. 2016 Nov - Dec; 15 (6):870-880
    View PubMed
  79. Croome KP, Lee DD, Burns JM, Saucedo-Crespo H, Perry DK, Nguyen JH, Taner CB, Mayo Clinic Collaborative in Transplant Research and Outcomes. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients. Liver Transpl. 2016 Aug; 22 (8):1099-106
    View PubMed
  80. Saucedo-Crespo H, Haakinson DJ, Croome KP, Mai ML, Taner CB, Heilman RL, Gonwa T. Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis. Clin Transplant. 2016 Jul; 30 (7):828-35 Epub 2016 June 09
    View PubMed
  81. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May-Jun; 15 (3):356-62
    View PubMed
  82. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May - Jun; 15 (3):356-362
    View PubMed
  83. Wadei HM, Lee DD, Croome KP, Mai ML, Golan E, Brotman R, Keaveny AP, Taner CB. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment. Am J Transplant. 2016 Mar; 16 (3):850-9 Epub 2015 Dec 11
    View PubMed
  84. Werlang ME, Palmer WC, Boyd EA, Cangemi DJ, Harnois DM, Taner CB, Stancampiano FF. Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. Clin Transplant. 2016 Jan; 30: (1)26-32.
    View PubMed
  85. Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, Taner CB. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016 Jan-Feb; 15 (1):53-60
    View PubMed
  86. Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, Taner CB. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016 Jan - Feb; 15 (1):53-60
    View PubMed
  87. Croome KP, Lee DD, Saucedo-Crespo H, Burns JM, Nguyen JH, Perry DK, Taner CB. A novel objective method for deceased donor and recipient size matching in liver transplantation. Liver Transpl. 2015 Dec; 21 (12):1471-7 Epub 2015 Nov 06
    View PubMed
  88. Giesbrandt KJ, Bulatao IG, Keaveny AP, Nguyen JH, Paz-Fumagalli R, Taner CB. Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. AJR Am J Roentgenol. 2015 Nov; 205 (5):976-84
    View PubMed
  89. Aniskevich S, Ladlie BL, Pai SL, Perry DK, Canabal JM, Taner CB. Postoperative Stroke Following Administration of Intraoperative Recombinant Tissue Plasminogen Activator for the Treatment of Intracardiac Thrombus During Liver Transplantation. J Cardiothorac Vasc Anesth. 2015 Oct; 29: (5)1314-8.
    View PubMed
  90. Peiris P, Pai SL, Aniskevich S 3rd, Crawford CC, Torp KD, Ladlie BL, Shine TS, Taner CB, Nguyen JH. Intracardiac thrombosis during liver transplant: A 17-year single-institution study. Liver Transpl. 2015 Oct; 21 (10):1280-5
    View PubMed
  91. Croome KP, Lee DD, Burns JM, Musto K, Paz D, Nguyen JH, Perry DK, Harnois DM, Taner CB. The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma. Am J Transplant. 2015 Oct; 15 (10):2704-11 Epub 2015 May 12
    View PubMed
  92. Bargehr J, Trejo-Gutierrez JF, Patel T, Rosser B, Aranda-Michel J, Yataco ML, Taner CB. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl. 2015 Mar; 21: (3)314-20.
    View PubMed
  93. Croome KP, Lee DD, Burns JM, Perry DK, Keaveny AP, Taner CB. Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States. PLoS One. 2015; 10 (10):e0140295 Epub 2015 Oct 15
    View PubMed
  94. Lee DD, Saucedo-Crespo H, Taner CB. Liver transplantation using grafts from donation after cardiac death donors. Current Surgery Reports. 2015; 3 (9):26
  95. Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP. Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation. 2014 Dec 27; 98(12):1323-30.
    View PubMed
  96. Lee DD, Singh A, Burns JM, Perry DK, Nguyen JH, Taner CB. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival. Liver Transpl. 2014 Dec; 20 (12):1447-53
    View PubMed
  97. Bulatao IG, Heckman MG, Rawal B, Aniskevich S, Shine TS, Keaveny AP, Perry DK, Canabal J, Willingham DL, Taner CB. Avoiding stay in the intensive care unit after liver transplantation: a score to assign location of care. Am J Transplant. 2014 Sep; 14 (9):2088-96 Epub 2014 Aug 01
    View PubMed
  98. Li H, Stegall MD, Dean PG, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosberg CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M. Assessing the efficacy of kidney paired donation--performance of an integrated three-site program. Transplantation. 2014 Aug 15; 98 (3):300-5
    View PubMed
  99. Shah H, Hellinger WC, Heckman MG, Diehl N, Shalev JA, Willingham DL, Taner CB, Perry DK, Nguyen J. Surgical site infections after liver retransplantation: incidence and risk factors. Liver Transpl. 2014 Aug; 20(8):930-6. Epub 2014 Jun 24.
    View PubMed
  100. Yataco ML, Difato T, Bargehr J, Rosser BG, Patel T, Trejo-Gutierrez JF, Pungpapong S, Taner CB, Aranda-Michel J. Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience. Liver Int. 2014 Jul; 34(6):e105-10. Epub 2014 Mar 15.
    View PubMed
  101. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl. 2014 Jun; 20(6):728-35.
    View PubMed
  102. Lee DD, Croome KP, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Liver Transplantation at Mayo Clinic Florida. Clin Transpl. 2014; 83-90.
    View PubMed
  103. Aniskevich S, Taner CB, Perry DK, Robards CB, Porter SB, Thomas CS, Logvinov II, Clendenen SR. Ultrasound-guided transversus abdominis plane blocks for patients undergoing laparoscopic hand-assisted nephrectomy: a randomized, placebo-controlled trial. Local Reg Anesth. 2014; 7:11-6 Epub 2014 May 25
    View PubMed
  104. Wadei HM, Heckman MG, Rawal B, Taner CB, Farahat W, Nur L, Mai ML, Prendergast M, Gonwa TA. Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation. 2013 Aug 15; 96 (3):274-81
    View PubMed
  105. Bargehr J, Trejo-Gutierrez JF, Rosser BG, Patel T, Yataco ML, Pungpapong S, Taner CB, Aranda-Michel J. Liver transplantation in patients with atrial fibrillation. Transplant Proc. 2013 Jul-Aug; 45(6):2302-6.
    View PubMed
  106. Mai ML, Mai WK, Taner CB, Prendergast MB, Wadei HM, Gonwa TA. Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function. Transplant Proc. 2013 May; 45(4):1528-30.
    View PubMed
  107. Sibulesky L, Heckman MG, Taner CB, Canabal JM, Diehl NN, Perry DK, Willingham DL, Pungpapong S, Rosser BG, Kramer DJ, Nguyen JH. Outcomes following liver transplantation in intensive care unit patients. World J Hepatol. 2013 Jan 27; 5 (1):26-32
    View PubMed
  108. Schinstock C, Dean PG, Li H, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosbergl CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M, Stegall MD. Desensitization in the era of kidney paired donation: the Mayo Foundation 3-site experience. Clin Transpl. 2013; 235-9.
    View PubMed
  109. Taner CB, Bulatao IG, Arasi LC, Perry DK, Willingham DL, Sibulesky L, Rosser BG, Canabal JM, Nguyen JH, Kramer DJ. Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts. Ann Hepatol. 2012 Sep-Oct; 11 (5):679-85
    View PubMed
  110. Leaphart CL, Gonwa TA, Mai ML, Prendergast MB, Wadei HM, Tepas JJ 3rd, Taner CB. Formal quality improvement curriculum and DMAIC method results in interdisciplinary collaboration and process improvement in renal transplant patients. J Surg Res. 2012 Sep; 177 (1):7-13 Epub 2012 Mar 30
    View PubMed
  111. Taner CB, Bulatao IG, Perry DK, Sibulesky L, Willingham DL, Kramer DJ, Nguyen JH. Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int. 2012 Aug; 25(8):838-46. Epub 2012 Jun 15.
    View PubMed
  112. Taner CB, Willingham DL, Bulatao IG, Shine TS, Peiris P, Torp KD, Canabal J, Nguyen JH, Kramer DJ. Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation. Liver Transpl. 2012 Mar; 18 (3):361-9
    View PubMed
  113. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012 Jan; 18 (1):100-11
    View PubMed
  114. Taner CB, Ung RL, Rosser BG, Aranda-Michel J. Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years. Hepatol Int. 2012 Jan; 6 (1):403-7 Epub 2011 June 18
    View PubMed
  115. Perry DK, Willingham DL, Sibulesky L, Bulatao IG, Nguyen JH, Taner CB. Should donation after cardiac death liver grafts be used for retransplantation? Ann Hepatol. 2011 Oct-Dec; 10 (4):482-5
    View PubMed
  116. Clendenon JN, Aranda-Michel J, Krishna M, Taner CB, Willingham DL. Recurrent liver failure caused by IgG4 associated cholangitis. Ann Hepatol. 2011 Oct-Dec; 10(4):562-4.
    View PubMed
  117. Hellinger WC, Heckman MG, Crook JE, Taner CB, Willingham DL, Diehl NN, Zubair AC, Shalev JA, Nguyen JH. Association of surgeon with surgical site infection after liver transplantation. Am J Transplant. 2011 Sep; 11 (9):1877-84 Epub 2011 Aug 09
    View PubMed
  118. Taner CB, Mughal D, Aranda-Michel J. Liver retransplantation in superobese patients: a single center experience. Transplant Proc. 2011 Jun; 43(5):1757-9.
    View PubMed
  119. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17 (6):641-9
    View PubMed
  120. Sibulesky L, Heckman MG, Perry DK, Taner CB, Willingham DL, Nguyen JH. A single-center experience with biliary reconstruction in retransplantation: duct-to-duct or Roux-en-Y choledochojejunostomy. Liver Transpl. 2011 Jun; 17(6):710-6.
    View PubMed
  121. Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation. Clin Transplant. 2011 May-Jun; 25(3):E345-55. Epub 2011 Mar 23.
    View PubMed
  122. Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl. 2011 May; 17(5):548-55.
    View PubMed
  123. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  124. Dayangac M, Taner CB, Akin B, Uraz S, Balci D, Duran C, Ayanoglu O, Killi R, Yuzer Y, Tokat Y. Dual left lobe living donor liver transplantation using donors unacceptable for right lobe donation: a case report. Transplant Proc. 2010 Dec; 42(10):4560-3.
    View PubMed
  125. Sibulesky L, Peiris P, Taner CB, Kramer DJ, Canabal JM, Nguyen JH. Intraoperative intracardiac thrombosis in a liver transplant patient. World J Hepatol. 2010 May 27; 2 (5):198-200
    View PubMed
  126. Sibulesky L, Willingham D, Taner C, Perry D, Nguyen J. Successful Simultaneous Laparoscopic Hand-Assisted Bilateral Nephrectomy and Living Donor Kidney Transplantation For Polycystic Kidney Disease. Abdominal Surgery. 2010 Winter/Spring 2011:11-12.
  127. Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Use of middle hepatic vein in right lobe living donor liver transplantation. Transpl Int. 2010 Mar 1; 23(3):285-91. Epub 2009 Oct 12.
    View PubMed
  128. Taner B, Willingham DL, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB. Polycystic liver disease and liver transplantation: single-institution experience. Transplant Proc. 2009 Nov; 41: (9)3769-71.
    View PubMed
  129. Sibulesky L, Nguyen JH, Paz-Fumagalli R, Taner CB, Dickson RC. Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C. World J Gastroenterol. 2009 Oct 28; 15 (40):5010-3
    View PubMed
  130. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15 (9):1028-35
    View PubMed
  131. Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation. 2009 Jan 27; 87(2):227-32.
    View PubMed
  132. Sibulesky L, Taner CB, Willingham DL, Satyanarayana R, Peiris P, Krishna M, Miiller JL, Nguyen JH. Orthotopic Liver Transplantation for Hepatic Adenoma in a Patient with Portal Vein Agenesis. Open Transplantation Journal. 2009; 3:22-5.
  133. Taner CB, Bathala V, Nguyen JH. Primary nonfunction in liver transplantation: a single-center experience. Transplant Proc. 2008 Dec; 40(10):3566-8.
    View PubMed
  134. Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Donor safety and remnant liver volume in living donor liver transplantation. Liver Transpl. 2008 Aug; 14(8):1174-9.
    View PubMed
  135. Taner CB, Nguyen JH. Mesocaval shunt as an alternative treatment for persistent ascites after liver transplantation: case reports. Transplant Proc. 2008 Jun; 40(5):1534-5.
    View PubMed
  136. Balci D, Taner B, Dayangac M, Akin B, Yaprak O, Duran C, Uraz S, Hayzaran S, Ayanoglu O, Killi R, Senturk H, Yuzer Y, Tokat Y. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report. Transplant Proc. 2008 Jun; 40(5):1786-8.
    View PubMed
  137. Smoot RL, Oderich GS, Taner CB, Greenlee SM, Larson DR, Cragun EB, Farley DR. Postoperative hematoma following inguinal herniorrhaphy: patient characteristics leading to increased risk. Hernia. 2008 Jun; 12 (3):261-5 Epub 2007 Dec 04
    View PubMed
  138. Duran C, Taner B, Dayangac M, Akin B, Balci D, Kurt Z, Killi R, Yuzer Y, Tokat Y. Why we did not use this donor. Liver Transpl. 2007 Aug; 13(8):1199-200.
    View PubMed
  139. Smoot RL, Taner CB, Farley DR. An axillary mass with no primary source. Contemp Surg. 2006; 62(4):171-6.
  140. Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy. 2004 Aug; 24 (8):1002-12
    View PubMed
  141. Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004 Jan; 8 (1):83-9; discussion 89
    View PubMed
  142. Smoot R, Farres H, Taner CB. Perforation of small bowel diverticulum. Contemp Surg. 2004; 60(7):319-22.
  143. Warnecke G, Severson SR, Ugurlu MM, Taner CB, Logan JS, Diamond LE, Miller VM, McGregor CG. Endothelial function in pigs transgenic for human complement regulating factor. Transplantation. 2002 Apr 15; 73 (7):1060-7
    View PubMed
  144. Taner CB, Severson SR, Best PJ, Lerman A, Miller VM. Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia. J Appl Physiol (1985). 2001 Mar; 90 (3):816-20
    View PubMed
  145. Pellegrini C, Jeppsson A, Taner CB, O'Brien T, Miller VM, Tazelaar HD, McGregor CG. Highly efficient ex vivo gene transfer to the transplanted heart by means of hypothermic perfusion with a low dose of adenoviral vector. J Thorac Cardiovasc Surg. 2000 Mar; 119 (3):493-500
    View PubMed
  146. Jeppsson A, Pellegrini C, O'Brien T, Miller VM, Tazelaar HD, Taner CB, McGregor CG. Gene transfer of endothelial nitric oxide synthase to pulmonary allografts: impact on acute rejection. Transpl Int. 2000; 13 Suppl 1:S591-6
    View PubMed
PST-20224350